Demographic | Age | 41 (19–80) | 42 (19–76) | NS |
Gender: M (%) | 143 (67.5) | 62 (80.5) | <0.05 |
African-Caribbean (%) | 100 (47.2) | 43 (55.8) | NS |
Clinical | Liver transplant (%) | 9 (4.3) | 0 (0) | NS |
Hepatocellular carcinoma (%) | 14 (6.8) | 0 (0) | 0.014 |
Bilirubin | 11 (3–148) | 12 (4–37) | NS |
AST | 29 (12–215) | 40 (20–328) | <0.001 |
INR | 1.05 (0.88–1.86) | 1.05 (0.94–2.47) | NS |
Albumin | 44 (24–52) | 44 (29–50) | NS |
VD and Bone markers | Baseline Vitamin D (g/l) | 14.2 (0–49) | 16.1 (6–50) | NS |
12 months Vitamin D (g/l) | 14.5 (0–44.5) | 13.6 (4.2–43.5) | NS |
Baseline Calcium mmol/l | 2.24 (2.01–2.41) | 2.25 (2.08–2.4) | NS |
12 months Calcium mmol/l | 2.23 (2.08–2.35) | 2.23 (2.10–2.37) | NS |
Baseline Phosphate mmol/l | 0.99 (0.38–1.71) | 0.91 (0.58–1.27) | 0.011 |
12 months Phosphate mmol/l | 1.06 (0.43–1.43) | 0.96 (0.55–1.43) | 0.017 |
Baseline ALP IU/l | 72 (39–325) | 70 (42–229) | NS |
12 months ALP IU/l | 75 (42–769) | 68 (36–168) | 0.004 |